TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/24 21:46 | 3/21/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | D | S.m | -34,100 | 40.86 | 0 | -834 | -23 | 2,794 | I | |||||||||||||||
2/1/24 17:58 | 1/30/24 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | D | P | 5,000 | 31.00 | 0 | 161 | 5 | 3,628 | I | |||||||||||||||
9/21/23 17:10 | 9/19/23 | RYZB | Rayzebio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | D | P.d | 8,500 | 18.00 | 0 | 472 | 64 | 1,210 | I | |||||||||||||||
7/6/21 16:27 | 7/2/21 | AVTE | Aerovate Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Katabi Maha | MA | DT | P.d | 5,000 | 14.00 | 0 | 357 | 10 | 3,759 | I | |||||||||||||||
5/18/21 20:17 | 5/18/21 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | DT | P.d | 8,000 | 11.00 | 0 | 727 | 33 | 2,915 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |